Most Recent
‘Elephant in the room’: Judge questions conduct of some lawyers for Banksia legal team
Last week’s judgment denouncing the scandalous behaviour of the legal team running the Banksia Securities class action cast a spotlight on the conduct of lawyers for some of the defendants, asking whether “untenable” defences were maintained beyond an acceptable point in the case.
‘Arrogant’ barristers in Banksia class action struck off roll, face criminal probe
Lawyers running the scandal-ridden Banksia class action have been struck from the roll of practitioners, will face criminal investigation and must pay group members $11.7 million in damages.
Day of reckoning arrives for Banksia class action lawyers
It has been described as the darkest chapter in Victoria's legal history, an exemplar of all that is terrible with class actions in Australia. A case of greedy lawyers who found their golden egg in a group of retirees who had lost their life savings, never thinking the chickens might come home to roost. Until now.
Halifax investors file Full Court appeal to boost recovery
Approximately 1,000 investors of collapsed stockbroker Halifax Investment Services have challenged a court decision concerning the date of the realisation of their investments which decreased the amounts they could recoup from the company's liquidation.
Solicitor denied procedural fairness in harassment investigation, appeals court finds
Victoria's State Revenue Office breached its obligations and denied procedural fairness to a senior solicitor who was fired after an investigation into alleged harassment, the state's Court of Appeal has found.
Sydney sues Telstra to block payphone installations
The city of Sydney has sued Telstra to block the telecommunications giant from carrying out the allegedly unlawful replacement and installation of payphones throughout the CBD area.
Pharmacor takes aim at Novartis patents for MS drug Gilenya
Generic drug company Pharmacor has fired back in a patent lawsuit by Novartis, filing a cross-claim seeking to invalidate the Swiss drug giant's patents for its blockbuster MS drug Gilenya.
Novartis wins injunction to stop generic version of blockbuster MS drug, for now
Swiss drug giant Novartis has secured an injunction temporarily blocking drug maker Pharmacor from launching a generic version of the company’s top-selling MS drug Gilenya in Australia.
Banksia silk’s refusal to give evidence while seeking to reopen defence ‘inexcusable’, judge says
Allowing former senior barrister Norman O'Bryan to reopen his defence in the Banksia class action while "avoiding the witness box" was clearly prejudicial, and futile to boot, a judge has said in his reasons for refusing the silk's last-minute application.
Banksia silk Norman O’Bryan signals possible appeal after failure to reopen defence
Once high-flying barrister Norman O'Bryan might seek to challenge a refusal by the judge overseeing the Banksia class action to revisit his abandoned defence and accept into evidence a document he claims proved he did not secretly hold shares in the funder behind the case.